Prescription drug co-payments and cost-related medication underuse

Publisher： Cambridge University Press

E-ISSN： 1744-134x|3|1|51-67

ISSN： 1744-1331

Source： Health Economics, Policy and Law, Vol.3, Iss.1, 2008-01, pp. : 51-67

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of the phased abolition of co‐payments on the utilisation of selected prescription medicines in Wales

By  

HEALTH ECONOMICS, Vol. 27, Iss. 1, 2018-01 ,pp. : 236-243

John Wiley & Sons Inc

Access to resources Recommend Favorite

Co-payments in the NHS: an analysis of the normative arguments

By  

Health Economics, Policy and Law, Vol. 5, Iss. 2, 2010-04 ,pp. : 225-246

Cambridge University Press

Access to resources Recommend Favorite

Estimating allocative inefficiency in the prescription drug industry

By Guell Robert C.   Fischbaum Marvin  

Applied Economics Letters, Vol. 4, Iss. 7, 1997-07 ,pp. : 419-423

Routledge Ltd

Access to resources Recommend Favorite

A model of state-level prescription drug expenditures in the USA

By Suraratdecha Chutima  

Applied Economics Letters, Vol. 3, Iss. 5, 1996-05 ,pp. : 289-292

Routledge Ltd

Access to resources Recommend Favorite

Providing Prescription Drug Coverage to the Elderly: America's Experiment with Medicare Part D

By Duggan Mark   Healy Patrick   Morton Fiona Scott  

The Journal of Economic Perspectives, Vol. 22, Iss. 4, 2008-0 ,pp. : 69-92

American Economic Association

Access to resources Recommend Favorite